Free Trial

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Teacher Retirement System of Texas

LeMaitre Vascular logo with Medical background

Teacher Retirement System of Texas lessened its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 73.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,534 shares of the medical instruments supplier's stock after selling 75,317 shares during the period. Teacher Retirement System of Texas owned approximately 0.12% of LeMaitre Vascular worth $2,226,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Opal Wealth Advisors LLC purchased a new position in shares of LeMaitre Vascular during the first quarter worth $26,000. Smartleaf Asset Management LLC increased its holdings in LeMaitre Vascular by 234.4% in the fourth quarter. Smartleaf Asset Management LLC now owns 418 shares of the medical instruments supplier's stock valued at $39,000 after buying an additional 293 shares in the last quarter. CBIZ Investment Advisory Services LLC increased its holdings in LeMaitre Vascular by 38.5% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 421 shares of the medical instruments supplier's stock valued at $39,000 after buying an additional 117 shares in the last quarter. NBC Securities Inc. acquired a new stake in shares of LeMaitre Vascular in the first quarter valued at about $36,000. Finally, Huntington National Bank grew its position in shares of LeMaitre Vascular by 64.9% in the fourth quarter. Huntington National Bank now owns 1,156 shares of the medical instruments supplier's stock valued at $107,000 after purchasing an additional 455 shares during the period. Hedge funds and other institutional investors own 84.64% of the company's stock.

Insider Activity

In other news, CEO George W. Lemaitre sold 4,399 shares of LeMaitre Vascular stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $85.10, for a total value of $374,354.90. Following the sale, the chief executive officer owned 1,827,003 shares in the company, valued at $155,477,955.30. This trade represents a 0.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders have sold a total of 100,000 shares of company stock valued at $8,556,857 in the last quarter. 9.50% of the stock is owned by company insiders.

LeMaitre Vascular Price Performance

Shares of NASDAQ LMAT traded down $2.07 during trading on Friday, hitting $83.68. The company had a trading volume of 84,551 shares, compared to its average volume of 169,936. The stock has a fifty day simple moving average of $82.72 and a two-hundred day simple moving average of $88.14. LeMaitre Vascular, Inc. has a fifty-two week low of $71.42 and a fifty-two week high of $109.58. The firm has a market capitalization of $1.89 billion, a price-to-earnings ratio of 42.26, a price-to-earnings-growth ratio of 2.26 and a beta of 0.82. The company has a quick ratio of 13.83, a current ratio of 16.49 and a debt-to-equity ratio of 0.48.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last announced its earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.02). LeMaitre Vascular had a net margin of 19.96% and a return on equity of 13.53%. The company had revenue of $59.87 million during the quarter, compared to analyst estimates of $57.61 million. During the same quarter last year, the business earned $0.44 EPS. The firm's revenue for the quarter was up 12.0% compared to the same quarter last year. On average, research analysts expect that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current year.

LeMaitre Vascular Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th were given a $0.20 dividend. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $0.80 annualized dividend and a dividend yield of 0.96%. LeMaitre Vascular's dividend payout ratio (DPR) is 40.40%.

LeMaitre Vascular Company Profile

(Free Report)

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.

Further Reading

Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Should You Invest $1,000 in LeMaitre Vascular Right Now?

Before you consider LeMaitre Vascular, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LeMaitre Vascular wasn't on the list.

While LeMaitre Vascular currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines